Schneeberger Daniel: insider trades.
Schneeberger Daniel reported 24 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 24 open-market purchases ($6.6M) and 0 sales, across 3 companies.
- Transactions
- 24
- Purchases (P)
- 24
- Sales (S)
- 0
- Companies
- 3
- Name as filed
- Schneeberger Daniel
Companies
| Company | Relationship | Transactions |
|---|---|---|
| NextCure, Inc. (NXTC) | TenPercentOwner | 13 |
| Tenax Therapeutics, Inc. (TENX) | TenPercentOwner | 7 |
| InMed Pharmaceuticals Inc. (INM) | TenPercentOwner | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | InMed Pharmaceuticals Inc. | P | 8,340 | $1.29 | 892,101 | Form 4 |
| 2026-09-15 | InMed Pharmaceuticals Inc. | P | 54,256 | $1.3 | 883,761 | Form 4 |
| 2026-09-14 | InMed Pharmaceuticals Inc. | P | 28,505 | $1.29 | 829,505 | Form 4 |
| 2026-09-03 | Tenax Therapeutics, Inc. | P | 900,000 | $1.78 | 6,524,151 | Form 4 |
| 2026-09-02 | Tenax Therapeutics, Inc. | P | 187,704 | $1.8 | 5,624,151 | Form 4 |
| 2026-09-01 | Tenax Therapeutics, Inc. | P | 179,058 | $1.8 | 5,436,447 | Form 4 |
| 2026-08-31 | Tenax Therapeutics, Inc. | P | 403,571 | $1.79 | 5,257,389 | Form 4 |
| 2026-08-24 | Tenax Therapeutics, Inc. | P | 107,374 | $1.75 | 4,853,818 | Form 4 |
| 2026-08-21 | Tenax Therapeutics, Inc. | P | 716,369 | $1.77 | 4,746,444 | Form 4 |
| 2026-08-20 | Tenax Therapeutics, Inc. | P | 202,124 | $1.78 | 4,030,075 | Form 4 |
| 2026-07-31 | NextCure, Inc. | P | 8,003 | $4.8 | 722,419 | Form 4 |
| 2026-07-31 | NextCure, Inc. | P | 3,300 | $4.98 | 689,416 | Form 4 |
| 2026-07-31 | NextCure, Inc. | P | 25,000 | $4.98 | 714,416 | Form 4 |
| 2026-07-30 | NextCure, Inc. | P | 50,000 | $4.97 | 443,266 | Form 4 |
| 2026-07-30 | NextCure, Inc. | P | 20,000 | $5 | 463,266 | Form 4 |
| 2026-07-30 | NextCure, Inc. | P | 20,000 | $5 | 483,266 | Form 4 |
| 2026-07-30 | NextCure, Inc. | P | 25,000 | $4.81 | 508,266 | Form 4 |
| 2026-07-30 | NextCure, Inc. | P | 77,850 | $4.96 | 686,116 | Form 4 |
| 2026-07-30 | NextCure, Inc. | P | 100,000 | $4.9 | 608,266 | Form 4 |
| 2026-07-29 | NextCure, Inc. | P | 1,810 | $5 | 391,666 | Form 4 |
| 2026-07-29 | NextCure, Inc. | P | 1,600 | $5 | 393,266 | Form 4 |
| 2026-07-28 | NextCure, Inc. | P | 6,400 | $4.95 | 389,856 | Form 4 |
| 2026-07-27 | NextCure, Inc. | P | 7,798 | $5 | 383,456 | Form 4 |
| 2026-07-15 | InMed Pharmaceuticals Inc. | P | 1,000 | $1.56 | 801,000 | Form 4 |
Questions
What stock did Schneeberger Daniel buy or sell?
Schneeberger Daniel reported 24 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 24 open-market purchases ($6.6M) and 0 sales, across 3 companies.
Is Schneeberger Daniel the same person as other filers with this name?
This page covers SEC CIK 1861120 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schneeberger-daniel-1861120.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.